Medivation Still Has MDV3100 + Cash
Dimebon Dropped Following Phase III Huntington's Failure
By Tom Wall
Tuesday, April 12, 2011
One analyst called it a "foregone conclusion." Another said it had "close to zero probability to succeed."
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.